顺行与逆行开放肠系膜旁路术治疗慢性肠系膜缺血的比较:多中心研究
该多中心回顾性研究比较了顺行(AG)与逆行(RG)开放肠系膜旁路术治疗慢性肠系膜缺血(CMI)的围术期和中期结局。共纳入209例患者(AG 130例,RG 79例),两组30天死亡率、并发症及移植物通畅率相似,但倾向性匹配队列中RG组1年死亡率较高。结论支持根据解剖、移植物可用性、合并症及机构经验个体化选择旁路配置。
要点
- AG与RG旁路术的围术期并发症和30天死亡率无显著差异。
- 两组移植物一期通畅率均优异且可比(1年97% vs 98%,3年90% vs 90%)。
- 倾向性匹配队列中RG组1年死亡率较高(36.8% vs 16.3%),需个体化选择。
核心结论
- AG与RG旁路术的围术期并发症和移植物通畅率相似,旁路配置并非独立预后因素。
- 倾向性匹配队列中RG组1年死亡率较高,支持基于解剖、移植物、合并症和经验个体化选择。
研究设计与样本
- 回顾性多中心队列研究,纳入2000-2024年间两家高容量中心因CMI行开放肠系膜旁路术的连续患者。
- 共209例患者,AG组130例(均来自中心A),RG组79例(中心A 36例,中心B 43例)。
- 采用多变量logistic回归、Cox模型和倾向性匹配队列进行校正比较,Kaplan-Meier法估计生存和通畅率。
主要发现
- 一期通畅率优异且可比(1年:97%±2% AG vs 98%±2% RG;3年:90%±8% vs 90%±9%;P=NS)。
- 多变量分析中旁路配置与死亡率(HR 1.4,95%CI 0.7-2.7,P=0.3)或围术期并发症(OR 0.93,95%CI 0.3-2.5,P=0.9)无独立关联。
临床怎么用
- AG和RG旁路术均可作为CMI开放旁路的选择,围术期风险和移植物通畅率相似。
- 旁路配置选择应基于解剖因素、移植物可用性、患者合并症和机构经验个体化决定。
- RG旁路术后1年死亡率可能较高,需加强术后监测和合并症管理。
局限性
- 回顾性研究设计,存在选择偏倚和混杂因素。
- AG组全部来自中心A,RG组来自两个中心,存在中心效应。
- 样本量有限,倾向性匹配队列样本较小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Contemporary clinical practice guidelines recommend an endovascular-first approach for chronic mesenteric ischemia (CMI), reserving open mesenteric bypass (OMB) for flush ostial vessel occlusion, long-segment disease, heavily calcified lesions, or failed stents. However, guidelines are equivocal regarding bypass configuration, leaving the optimal strategy debated. The antegrade (AG) approach may carry higher perioperative risk due to supramesenteric aortic cross-clamping, whereas the retrograde (RG) approach from the infrarenal aorta or iliac vessels raises concerns about long-term patency. Therefore, we compared perioperative and midterm outcomes of AG and RG bypass in a multi-institutional cohort. METHODS: We retrospectively reviewed consecutive patients undergoing OMB for CMI at two high-volume centers (2000-2024). The primary end point was 30-day mortality; secondary end points included complications, survival, and patency. Adjusted comparisons were performed using multivariable logistic regression, Cox models, and propensity-matched cohorts. Kaplan-Meier methods estimated survival and patency. RESULTS: A total of 209 patients underwent OMB: 130 AG (all from center A) and 79 RG (36 from center A, 43 from center B). Compared with AG, RG patients had higher rates of cardiopulmonary comorbidity, including chronic obstructive pulmonary disease (57% vs 44%; P = .08) and congestive heart failure (26% vs 12%; P = .01), were more frequently transferred from other hospitals (29% vs 15%; P = .02), and more often received autogenous vein conduit (55% vs 1%; P < .0001). Unadjusted complication rates (22% vs 22%; P = 1), 30-day mortality (4.4% vs 8.7%; P = .3), and 90-day mortality (10% vs 15%; P = .5) were similar between groups. Primary patency was excellent and comparable (1-year: 97% ± 2% AG vs 98 ± 2% RG; 3-year: 90% ± 8% vs 90% ± 9%; P = NS). On multivariable analysis, bypass configuration was not independently associated with mortality (hazard ratio, 1.4; 95% confidence interval [CI], 0.7-2.7; P = .3) or perioperative complications (odds ratio, 0.93; 95% CI, 0.3-2.5; P = .9). In the propensity-matched cohort (65 AG vs 65 RG), early outcomes and patency remained similar; however, 1-year mortality was higher after RG bypass (36.8% vs 16.3%; odds ratio, 3.0; 95% CI, 1.2-8; P = .02). Overall survival in the full cohort did not differ significantly by Kaplan-Meier analysis (log-rank P = .5). CONCLUSIONS: In this multi-institutional analysis of patients with CMI undergoing OMB, AG and RG configurations demonstrated similar perioperative morbidity and excellent graft patency. Bypass configuration was not independently associated with early or midterm outcomes in adjusted analyses, although higher 1-year mortality was observed after RG bypass in a propensity-matched cohort. These findings support individualized selection of bypass configuration based on anatomic considerations, conduit availability, patient comorbidity, and institutional expertise.
引用
- Fazzone BJ, Scali ST, Albrecht P, et al. A multi-institutional study comparing antegrade and retrograde open mesenteric bypass for chronic mesenteric ischemia. J Vasc Surg. 2026. PMID: 41967730. doi:10.1016/j.jvs.2026.03.613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。